Proactive Investors - Run By Investors For Investors

WideCells's chief hails "very exciting times" for the group after Biovault agreement

Joao Andrade, chief executive at stem cells specialist WideCells Group (LON:WDC) talks to Proactive Investors about the definitive agreement the group signed in the UK with Biovault Technical,  which will facilitate the first sales of CellPlan to Biovault’s customer base.

"We are now very excited because we awere now able to reach an agreement with Biovault. Biovault is one of the cord blood banks in the world operating to the highest quality standards and that's really the type of company we would like to start working with," he says. "This is a very exciting time for us," he adds.

Discussing the commercial strategy for CellPlan sales he says: "we are expecting the uptake to be increasing as the year develops."

"This type of product is able to generate revenue for a number years."

Meet Premier African Minerals Ltd, Anglo Asian Mining Plc and Thor Mining PLC at our event, London, 21 September 2017. Register here »
View full WDC profile View Profile

WideCells Group Timeline

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use